Evidence-based consensus on positioning of SGLT2i in type 2 diabetes mellitus in Indians
95% CI, 1.61-1.71) compared to those with MASLD
Body Mass Index (BMI): You have a documented body mass index (BMI) of 30 kg/m2 or higher, or your initial BMI is 27 kg/m2 or higher with at least one weight-related comorbid condition, such as a documented medical history of high blood pressure, high cholesterol, type 2 diabetes mellitus, or obstructive sleep apnea
The answer is that people with type 1 diabetes are not exempt from other illnesses or causes of ill health
Fatigue that persists beyond 46 weeks, worsens despite supplementation, or significantly limits daily function warrants a provider conversation about dose reduction, temporary pause, or alternative therapy